Nanotechnology in Medicine - Thematic Research

Nanotechnology in Medicine - Thematic Research


Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the ability to target specific cells or tissues. These materials are produced on a nanoscale level and are safe to introduce into the body. Applications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs that will help medical professionals treat various diseases. In addition to targeted delivery of therapeutics, nanotechnology can also be used to release drugs in a controlled manner. This can result in improved outcomes for patients due to a reduction in toxicity, more efficient delivery of therapeutic molecules, and longer lifetime of drugs within the body.

Key Highlights

  • Players in the nanomedicine market range from private companies that make small annual revenues to large companies that dominate multiple industries, generating large revenues from many patents and FDA-approved drugs.
  • Nanomedicines are a combination of nanotechnology with the drug itself, and are required to pass standard regulatory milestones. This includes proven safety and efficacy based on pre-clinical and clinical trials.
  • Nanotechnologies are used as imagine contrast agents (microbubbles), for diagnostic purposes (liposomes and nanoparticles) and therapy (liposomes, nanoparticles and therapeutic microbubbles in development).
  • This thematic report provides an overview of the use of nanotechnology in the medical device field.
  • The key trends within this theme include understanding different patient populations and target specification.
  • Our unique thematic analysis dives deep into the major sub-segments of nanotechnology in medicine, including liposomes, microbubbles and nanoparticles, and the market outlook for each type of technology.
  • Companies that dominate the nanotechnology in medicine theme include Janssen, Gilead, GE Healthcare and Sanofi.
Reasons to buy
  • Understand the nanotechnology industry through accessing the impacts and observing case studies identifying the key leaders, those who are likely to disrupt and those who fell behind.
  • Assess the different types of nanoparticles, their current use in medicine and their future outlook.
  • GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.

  • Introduction
  • Players
    • Table Figure 1: Who are the leaders and disruptors in the nanomedicine value chain?
  • Trends
    • Technology/Scientific Trends
      • Table Technology/Scientific Trends
    • Macroeconomic Trends
      • Table Macroeconomic Trends
    • Regulatory Trends
      • Table Regulatory Trends
  • Industry Analysis
    • Market Segmentation
      • Table Figure 2: Nanotechnology in Medicine: Three Major Market Segments
    • Liposomes
      • Table Nanomedicines that have been approved by the FDA that use liposomes
      • Table Figure 3: Indications of FDA-approved nanomedicines using liposomes.
    • Microbubbles
      • Table Figure 4: Global Microbubble Market Value
      • Table Figure 5: US Microbubble Market Value
    • Nanoparticles
      • Table Nanomedicines that utilize PEG and have been approved by the FDA
      • Table Nanomedicines that utilize other nanoparticles and have been approved by the FDA
      • Table Figure 6: Composition of FDA-approved nanomedicines using nanoparticles
    • Generation of Revenue
      • Table Figure 7: US Nanomedicine ASPs(2019)
    • Competitive Analysis
    • Case Studies
      • Table Figure 8: Global Vyxeos Market Value
      • Table Figure 9: Global Rebinyn Market Value
    • Mergers and Acquisitions
      • Table Mergers and Acquisitions
    • Timeline
      • Table Figure 10: Timeline of FDA-Approved Nanomedicines
    • Clinical Trials
      • Table Figure 11: Nanotechnology in Medicine Clinical Trials - Oncology
  • Value Chain
    • Table Figure 12: The Nanomedicine Value Chain
  • Companies
    • Public Companies
      • Table Public Companies
    • Private Companies
      • Table Private Companies
  • Appendix: Our thematic research methodology
    • Viewing the world's data by themes makes it easier to make important decisions
    • Traditional research does a poor job of picking winners and losers
    • That is why we developed our "thematic engine"
    • How do we create our sector scorecards?
      • Table Figure 13: Our five-step approach for generating a sector scorecard
    • What is in our sector scorecards?
    • How do we score companies in our thematic screen?
    • How our research reports fit into our overall thematic research ecosystem
    • About the Author
    • About GlobalData
    • Contact us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook